Induction of surface antigen CD69 expression in T-lymphocytes following exposure to actinomycin D

International Journal of Immunopharmacology

Volumn 21, Issue 10, 1999, Pages 689-703

  Morgan, C D ^a   Greene Jr, J F ^a   Measel Jr, J W ^a  

^a Scott White Hospital and Clinic   (United States)

Author keywords

Actinomycin D; CD69 expression; T lymphocyte

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; DACTINOMYCIN; MEMBRANE ANTIGEN; MITOGENIC AGENT; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE; CONCENTRATION RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; B LYMPHOCYTE; BIOSYNTHESIS; DOSE RESPONSE; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; IMMUNOLOGY;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; CELL CYCLE; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; MITOGENS; T-LYMPHOCYTES;

EID: 0032873389     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00045-4     Document Type: Article

References (47)

1. Arguello F., Alexander M., Sterry J.A., Tudor G., Smith E.M., Kalavar N.T., Greene J.F. Jr, Koss W., Morgan C.D., Stinson S.F., Siford T.J., Alvord W.G., Klabansky R.L., Sausville E.A. Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity in vivo against human leukemia and lymphoma xenografts. Blood. 91:1998;2482-2490.
2. Bajorath J., Aruffo A. Molecular model of the extracellular lectin-like domain in CD69. J. Biol. Chem. 269:1994;32,457-32,463.
3. Beard S.E., Capaldi S.R., Gee P. Stress responses to DNA damaging agents in the human colon carcinoma cell line, RKO. Mutat. Res. 371:1996;1-13.
4. Bendelac A., Matzinger P., Seder R.A., Paul W.E., Schwartz R.H. Activation events during thymic selection. J. Exp. Med. 175:1992;731-742.
5. Bezouska K., Nepovim A., Horvath O., Pospisil M., Hamann J., Feizi T. CD69 antigen of human lymphocytes is a calcium-dependent carbohydrate-binding protein. Biochem. Biophys. Res. Commun. 208:1995;68-74.
6. Bieber T., Rieger A., Stingl G., Sander E., Wanek P., Strobel I. CD69, an early activation antigen on lymphocytes, is constitutively expressed by human epidermal Langerhans cells. J. Invest. Dermatol. 98:1992;771-776.
7. Biselli R., Matricardi P.M., D'Amelio R., Fattorossi A. Multiparametric flow cytometric analysis of the kinetics of surface molecule expression after polyclonal activation of human peripheral blood T lymphocytes. Scand. J. Immunol. 35:1992;439-447.
8. Chen J.C., Davis B.H., Leon M.A., Leong L.C. Gamma radiation induces CD69 expression on lymphocytes. Cytometry. 30:1997;304-312.
9. Cotter T.G. Induction of apoptosis in cells of the immune system by cytotoxic stimuli. Semin. Immunol. 4:1992;399-405.
10. Cotter T.G., Glynn J.M., Echeverri F., Green D.R. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res. 12:1992;773-779.
11. D'Ambrosio D., Trotta R., Vacca A., Frati L., Santoni A., Gulino A., Testi R. Transcriptional regulation of interleukin-2 gene expression by CD69-generated signals. Eur. J. Immunol. 23:1993;2993-2997.
12. D'Ambrosio D., Cantrell D.A., Frati L., Santoni A., Testi R. Involvement of p21ras activation in T cell CD69 expression. Eur. J. Immunol. 24:1994;616-620.
13. Das K.C., White C.W. Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C. J. Biol. Chem. 272:1997;14,914-14,920.
14. Dbaibo G.S., Pushkareva M.Y., Rachid R.A., Alter N., Smyth M.J., Obeid L.M., Hannun Y.A. P53-dependent ceramide response to genotoxic stress. J. Clin. Invest. 102:1998;329-339.
15. De Maria R., Cifone M.G., Trotta R., Rippo M.R., Festuccia C., Santoni A., Testi R. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J. Exp. Med. 180:1994;1999-2004.
16. Flescher E., Tripoli H., Salnikow K., Burns F.J. Oxidative stress suppresses transcription factor activities in stimulated lymphocytes. Clin. Exp. Immunol. 112:1998;242-247.
17. Gavioli R., Risso A., Smilovich D., Baldissarro I., Capra M.C., Bargellesi A., Cosulich M.E. CD69 molecule in human neutrophils: its expression and role in signal-transducing mechanisms. Cell. Immunol. 142:1992;186-196.
18. Hamann J., Fiebig H., Strauss M. Expression cloning of the early activation antigen CD69, a type II integral membrane protein with a C-type lectin domain. J. Immunol. 150:1993;4920-4927.
19. Jackman J., Alamo I. Jr, Fornace A.J. Jr. Genotoxic stress confers preferential and coordinate messenger RNA stability on the five gadd genes. Cancer Res. 54:1994;5656-5662.
20. Johannisson A., Thuvander A., Gadhasson I.L. Activation markers and cell proliferation as indicators of toxicity: a flow cytometric approach. Cell. Biol. Toxicol. 11:1995;355-366.
21. Kishimoto H., Surh C.D., Sprent J. Upregulation of surface markers on dying thymocytes. J. Exp. Med. 181:1995;649-655.
22. Lewis J.G., Adams D.O., Fan S. Selective sensitivity of macrophages to cytotoxicity by inhibitors of macromolecular synthesis: induction of apoptosis. J. Leukoc. Biol. 57:1995;635-642.
23. Maino V.C., Suni M.A., Ruitenberg J.J. Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry. 20:1995;127-133.
24. Marini M., Frabetti F., Musiani D., Franceschi C. Oxygen radicals induce stress proteins and tolerance to oxidative stress in human lymphocytes. Int. J. Radiat. Biol. 70:1996;337-350.
25. Marzio R., Jirillo E., Ransijn A., Manuel J., Corradin S.B. Expression and function of the early activation antigen CD69 in murine macrophages. J. Leukoc. Biol. 62:1997;349-355.
26. Merkenschlager M., Graf D., Lovatt M., Bommhardt U., Zamoyska R., Fisher A.G. How many thymocytes audition for selection? J. Exp. Med. 186:1997;1149-1158.
27. Nakamura K., Hori T., Yodoi J. Alternative binding of p56lck and phosphatidylinositol 3-kinase in T cells by sulfhydryl oxidation: implication of aberrant signaling due to oxidative stress in T lymphocytes. Mol. Immunol. 33:1996;855-865.
28. Overton W.R., Catalano E., McCoy J.P. Jr. Method to make paraffin-embedded breast and lymph tissue mimic fresh tissue in DNA analysis. Cytometry. 26:1996;166-171.
29. Riggs C.E. Jr. Antitumor antibiotics and related compounds. Perry M.C. The chemotherapy source book. 1997;345-385 Williams & Wilkins, Baltimore, MD.
30. Risso A., Smilovich D., Capra M.C., Baldissarro I., Yan G., Bargellesi A., Cosulich M.E. CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression. J. Immunol. 146:1991;4105-4114.
31. Sanchez-Mateos P., Sanchez-Madrid F. Structure-function relationship and immunochemical mapping of external and intracellular antigenic sites on the lymphocyte activation inducer molecule, AIM/CD69. Eur. J. Immunol. 21:1991;2317-2325.
32. Santis A.G., Lopez-Cabrera M., Sanchez-Madrid F., Proudfoot N. Expression of the early lymphocyte activation antigen CD69, a C-type lectin, is regulated by mRNA degradation associated with AU-rich sequence motifs. Eur. J. Immunol. 25:1995;2142-2146.
33. Simms P.E., Ellis T.M. Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation. Clin. Diagn. Lab. Immunol. 3:1996;301-304.
34. Slater A.F., Stefan C., Nobel I., van den Dobbelsteen D.J., Orrenius S. Signaling mechanisms and oxidative stress in apoptosis. Toxicol. Lett. 82:(83):1995;149-153.
35. Tassone P., Turco M.C., Tuccillo F., Bonelli P., Morrone G., Cecco L., Cerra M., Bond H., Di Nicola M., Gianni A.M., Venuta S. CD69 expression on primitive progenitor cells and hematopoietic malignancies. Tissue Antigens. 48:1996;65-68.
36. Taylor-Fishwick D.A., Siegel J.N. Raf-1 provides a dominant but not exclusive signal for the induction of CD69 expression on T cells. Eur. J. Immunol. 25:1995;3215-3221.
37. Testi R., Phillips J.H., Lanier L.L. Constitutive expression of a phosphorylated activation antigen (Leu 23) by CD3 bright human thymocytes. J. Immunol. 141:1988;2557-2563.
38. Testi R., Phillips J.H., Lanier L.L. T cell activation via Leu-23 (CD69). J. Immunol. 143:1989;1123-1128.
39. Testi R., Pulcinelli F., Frati I., Gazzaniga P.P., Santoni A. CD69 is expressed on platelets and mediates platelet activation and aggregation. J. Exp. Med. 172:1990;701-707.
40. Testi R., D'Ambrosio D., de Maria R., Santoni A. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today. 15:1994;479-483.
41. Tugores A., Alonso M.A., Sanchez-Madrid F., de Landazuri M.O. Human T cell activation through the activation-inducer molecule/CD69 enhances the activity of transcription factor AP-1. J. Immunol. 148:1992;2300-2306.
42. + thymocytes and identification of thymic emigrants. J. Immunol. 155:1995;1862-1872.
43. Werfel T., Boeker M., Kapp A. Rapid expression of the CD69 antigen on T cells and natural killer cells upon antigenic stimulation of peripheral blood mononuclear cell suspensions. Allergy. 52:1997;465-469.
44. Wong B., Arron J., Choi Y. T cell receptor signals enhance susceptibility to Fas-mediated apoptosis. J. Exp. Med. 186:1997;1939-1944.
45. Wu M.X., Ao Z., Daley J.F., Schlossman S.F. Induction and detection of apoptosis in human periphery blood T-cells. J. Immunol. Methods. 206:1997;153-162.
46. Ziegler S.F., Ramsdell F., Hjerrild K.A., Armitage R.J., Grabstein K.H., Hennen K.B., Farrah T., Fanslow W.C., Shevach E.M., Alderson M.R. Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur. J. Immunol. 23:1993;1643-1648.
47. Ziegler S.F., Ramsdell F., Alderson M.R. The activation antigen CD69. Stem Cells. 12:1994;456-465.